Previous studies suggested that GLP-1 diabetes and weight-loss drugs, such as semaglutide (brand name Wegovy or Ozempic), could worsen diabetic retinopathy and associated conditions
In clinical trials and studies that have been done on semaglutide, it has been found that patients who participated in these studies experienced a decrease of 5-10% of their overall body weight, with some reporting more or less than this
Common side effects include: Nausea Vomiting Diarrhea Constipation Headache Fatigue Indigestion These happen because the medication slows digestion and affects appetite signals in the brain and small intestine
Below is the crucial counseling information that needs to be addressed to the patient
This happens due to the increased resistance of protein towards denaturation and unfolding caused during processing (e.g., during freezing) (Chang et al., 1996, Carpenter, 1997)
A licensed EU doctor decides whether it's appropriate and safe for you